Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vectura Group Plc (VEC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7461
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases. The company develops products based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. Vectura has a varied portfolio of drugs in clinical development, comprising several novel and generic programs that are partnered with several global biotechnology and pharmaceutical companies. Vectura is headquartered in Chippenham, Wiltshire, the UK.

Vectura Group Plc (VEC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Vectura Group Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
SkyePharma Acquires Novel Inhaled Therapy Platform from Pulmagen Therapeutics 11
Partnerships 12
Ablynx Exercises Option for Licensing Agreement with Vectura 12
Vectura Enters into Agreement with Dynavax Technologies 13
Vectura Enters into Co-Development Agreement with Propeller Health 14
Activaero Enters Into Distribution Agreement With Vivisol For Akita Jet Inhalation System 15
Vectura, Tianjin KingYork Group And Zendex Bio Strategy Form Respiratory Joint Venture In China 16
Activaero Enters Into Co-Development Agreement With TransMIT 17
Merger 18
SkyePharma Merges with Vectura 18
Equity Offering 20
SkyePharma Completes Private Placement Of Shares For US$187 Million 20
SkyePharma Completes Rights Offering Of Shares 21
Vectura Group Completes Private Placement Of Shares For US$46 Million 22
Acquisition 23
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 23
Vectura Acquires Activaero, Medical Device Company, For US$181 Million 24
Vectura Group Plc – Key Competitors 26
Vectura Group Plc – Key Employees 27
Vectura Group Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Sep 11, 2018: Vectura Group: Interim Results 29
Mar 21, 2018: Vectura Group: 2017 Preliminary Results 38
Mar 21, 2018: Vectura Group: 2017 Preliminary Results – Performance in-line with expectations, with strong in-market growth from key inhaled products 39
Sep 06, 2017: Vectura Group: 2017 Interim Results 41
Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 43
Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 45
Corporate Communications 46
Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director 46
Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director 47
Apr 20, 2018: Vectura Announces Senior Management Change 48
Apr 20, 2018: Vectura Group: Directorate Change – Chief Financial Officer 49
Nov 29, 2017: Vectura Group appoints Juliet Thompson to its Board of Directors 50
Mar 06, 2017: Vectura Group: Board Change 51
Other Significant Developments 52
Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products 52
Jan 25, 2017: Seebri / Ultibro Breezhaler 2016 sales reach $512 million triggering $5 million milestone receipt 53
Jan 11, 2017: Vectura Group: Pre-close update 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Vectura Group Plc, Medical Equipment, Key Facts, 2017 2
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Deals By Market, 2012 to YTD 2018 9
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SkyePharma Acquires Novel Inhaled Therapy Platform from Pulmagen Therapeutics 11
Ablynx Exercises Option for Licensing Agreement with Vectura 12
Vectura Enters into Agreement with Dynavax Technologies 13
Vectura Enters into Co-Development Agreement with Propeller Health 14
Activaero Enters Into Distribution Agreement With Vivisol For Akita Jet Inhalation System 15
Vectura, Tianjin KingYork Group And Zendex Bio Strategy Form Respiratory Joint Venture In China 16
Activaero Enters Into Co-Development Agreement With TransMIT 17
SkyePharma Merges with Vectura 18
SkyePharma Completes Private Placement Of Shares For US$187 Million 20
SkyePharma Completes Rights Offering Of Shares 21
Vectura Group Completes Private Placement Of Shares For US$46 Million 22
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 23
Vectura Acquires Activaero, Medical Device Company, For US$181 Million 24
Vectura Group Plc, Key Competitors 26
Vectura Group Plc, Key Employees 27
Vectura Group Plc, Subsidiaries 28

List of Figures
Vectura Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rostelecom:企業の戦略・SWOT・財務情報
    Rostelecom - Strategy, SWOT and Corporate Finance Report Summary Rostelecom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sanford Health-医療機器分野:企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Aevi Genomic Medicine Inc (GNMX)-製薬・医療分野:企業M&A・提携分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company’s pipeline products include AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glutamaterg …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Koninklijke Vopak NV (VPK):石油・ガス:M&Aディール及び事業提携情報
    Summary Koninklijke Vopak NV (Vopak) is an independent tank storage company that stores and handles liquid oil products, chemicals, vegetable oils, biofuels and liquefied natural gases. It also offers logistics services, handles customs formalities and documentation for its customers at its terminal …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務分析
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Gentera SAB de CV (GENTERA):企業の財務・戦略的SWOT分析
    Gentera SAB de CV (GENTERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • DBS Bank (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Misonix Inc (MSON):企業の財務・戦略的SWOT分析
    Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • W. L. Gore & Associates Inc:企業の製品パイプライン分析
    Summary W. L. Gore & Associates Inc (Gore) is a materials science company serving diverse industries. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company develops products for medical implants; fabr …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Focus Media Holding Ltd:企業のM&A・事業提携・投資動向
    Focus Media Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Focus Media Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析
    Summary Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; a …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Oberg Industries Inc:企業の戦略的SWOT分析
    Oberg Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mobile Telesystems
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • J.L. Clark Inc:企業の戦略的SWOT分析
    J.L. Clark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆